메뉴 건너뛰기




Volumn 33, Issue 8, 2015, Pages 1205-1211

Prognostic role of nuclear factor/IB and bone remodeling proteins in metastatic giant cell tumor of bone: A retrospective study

Author keywords

bone remodeling; giant cell tumor; metastasis; prognostic biomarkers

Indexed keywords

CD68 ANTIGEN; GELATINASE A; INTERLEUKIN 1ALPHA; NUCLEAR FACTOR I; NUCLEAR FACTOR IB; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C FOS; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKER; UNCLASSIFIED DRUG; NFIB PROTEIN, HUMAN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN;

EID: 84936847442     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22873     Document Type: Article
Times cited : (30)

References (22)
  • 2
    • 77449093512 scopus 로고    scopus 로고
    • Metastatic giant cell tumor of bone: Are there associated factors and best treatment modalities?
    • Viswanathan S, Jambhekar NA,. 2010. Metastatic giant cell tumor of bone: are there associated factors and best treatment modalities? Clin Orthop Relat Res 468: 827-833.
    • (2010) Clin Orthop Relat Res , vol.468 , pp. 827-833
    • Viswanathan, S.1    Jambhekar, N.A.2
  • 3
    • 84868229928 scopus 로고    scopus 로고
    • Giant cell tumor of bone: A basic science perspective
    • Cowan RW, Singh G,. 2013. Giant cell tumor of bone: a basic science perspective. Bone 52: 238-246.
    • (2013) Bone , vol.52 , pp. 238-246
    • Cowan, R.W.1    Singh, G.2
  • 4
    • 79251470118 scopus 로고    scopus 로고
    • Identification of potential biomarkers for giant cell tumor of bone using comparative proteomics analysis
    • Conti A, Rodriguez GC, Chiechi A, et al., 2011. Identification of potential biomarkers for giant cell tumor of bone using comparative proteomics analysis. Am J Pathol 178: 88-97.
    • (2011) Am J Pathol , vol.178 , pp. 88-97
    • Conti, A.1    Rodriguez, G.C.2    Chiechi, A.3
  • 5
    • 84877135394 scopus 로고    scopus 로고
    • MicroRNA expression profiles in metastatic and non-metastatic giant cell tumor of bone
    • Mosakhani N, Pazzaglia L, Benassi MS, et al., 2013. MicroRNA expression profiles in metastatic and non-metastatic giant cell tumor of bone. Histol Histopathol 28: 671-678.
    • (2013) Histol Histopathol , vol.28 , pp. 671-678
    • Mosakhani, N.1    Pazzaglia, L.2    Benassi, M.S.3
  • 6
    • 84864276297 scopus 로고    scopus 로고
    • Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidences
    • Heymann D,. 2012. Anti-RANKL therapy for bone tumours: basic, pre-clinical and clinical evidences. J Bone Oncol. 1: 2-11.
    • (2012) J Bone Oncol. , vol.1 , pp. 2-11
    • Heymann, D.1
  • 7
    • 78650397541 scopus 로고    scopus 로고
    • Clinical development of anti-RANKL therapies for treatment and prevention of bone metastasis
    • Lipton A, Goessl C,. 2011. Clinical development of anti-RANKL therapies for treatment and prevention of bone metastasis. Bone 48: 96-99.
    • (2011) Bone , vol.48 , pp. 96-99
    • Lipton, A.1    Goessl, C.2
  • 8
    • 84894931059 scopus 로고    scopus 로고
    • Mapping protein signal pathway interaction in sarcoma bone metastasis: Linkage between rank, metalloproteinases turnover and growth factor signaling pathways
    • Conti A, Espina V, Chiechi A, et al., 2014. Mapping protein signal pathway interaction in sarcoma bone metastasis: linkage between rank, metalloproteinases turnover and growth factor signaling pathways. Clin Exp Metastasis 31: 15-24.
    • (2014) Clin Exp Metastasis , vol.31 , pp. 15-24
    • Conti, A.1    Espina, V.2    Chiechi, A.3
  • 9
    • 77954556987 scopus 로고    scopus 로고
    • Differential gene expression in classic giant cell tumours of bone: Tenascin C as biological risk factor for local relapses and metastases
    • Pazzaglia L, Conti A, Chiechi A, et al., 2010. Differential gene expression in classic giant cell tumours of bone: tenascin C as biological risk factor for local relapses and metastases. Histopathology 57: 59-72.
    • (2010) Histopathology , vol.57 , pp. 59-72
    • Pazzaglia, L.1    Conti, A.2    Chiechi, A.3
  • 10
    • 79960463418 scopus 로고    scopus 로고
    • Nuclear factor I/B is an oncogene in small cell lung cancer
    • Dooley AL, Winslow MM, Chiang DY, et al., 2011. Nuclear factor I/B is an oncogene in small cell lung cancer. Genes Dev 25: 1470-1475.
    • (2011) Genes Dev , vol.25 , pp. 1470-1475
    • Dooley, A.L.1    Winslow, M.M.2    Chiang, D.Y.3
  • 11
    • 81855166112 scopus 로고    scopus 로고
    • NFIB is a potential target for estrogen receptor-negative breast cancers
    • Moon HG, Hwang KT, Kim JA, et al., 2011. NFIB is a potential target for estrogen receptor-negative breast cancers. Mol Oncol 5: 538-544.
    • (2011) Mol Oncol , vol.5 , pp. 538-544
    • Moon, H.G.1    Hwang, K.T.2    Kim, J.A.3
  • 12
    • 84865603486 scopus 로고    scopus 로고
    • Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma
    • Buckle CH, De Leenheer E, Lawson MA, et al., 2012. Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma. PLoS ONE 7: e41127.
    • (2012) PLoS ONE , vol.7 , pp. e41127
    • Buckle, C.H.1    De Leenheer, E.2    Lawson, M.A.3
  • 13
    • 79952131163 scopus 로고    scopus 로고
    • RANKL expression is related to treatment outcome of patients with localized, high-grade osteosarcoma
    • Lee JA, Jung JS, Kim DH, et al., 2010. RANKL expression is related to treatment outcome of patients with localized, high-grade osteosarcoma. Pediatr Blood Cancer 56: 738-743.
    • (2010) Pediatr Blood Cancer , vol.56 , pp. 738-743
    • Lee, J.A.1    Jung, J.S.2    Kim, D.H.3
  • 14
    • 33947646303 scopus 로고    scopus 로고
    • Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B
    • Mori K, Le Goff B, Berreur M, et al., 2007. Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B. J Pathol. 211: 555-562.
    • (2007) J Pathol. , vol.211 , pp. 555-562
    • Mori, K.1    Le Goff, B.2    Berreur, M.3
  • 15
    • 80053185152 scopus 로고    scopus 로고
    • Formulated siRNAs targeting rankl prevent osteolysis and enhance chemotherapeutic response in osteosarcoma models
    • Rousseau J, Escriou V, Lamoureux F,. 2011. Formulated siRNAs targeting rankl prevent osteolysis and enhance chemotherapeutic response in osteosarcoma models. JBMR 26: 2452-2462.
    • (2011) JBMR , vol.26 , pp. 2452-2462
    • Rousseau, J.1    Escriou, V.2    Lamoureux, F.3
  • 16
    • 84877090907 scopus 로고    scopus 로고
    • Elevated TNFR1 and serotonin in bone metastasis are correlated with poor survival following bone metastasis diagnosis for both carcinoma and sarcoma primary tumors
    • Chiechi A, Novello C, Magagnoli G, et al., 2013. Elevated TNFR1 and serotonin in bone metastasis are correlated with poor survival following bone metastasis diagnosis for both carcinoma and sarcoma primary tumors. Clin Cancer Res 19: 2473-2485.
    • (2013) Clin Cancer Res , vol.19 , pp. 2473-2485
    • Chiechi, A.1    Novello, C.2    Magagnoli, G.3
  • 17
    • 78650304107 scopus 로고    scopus 로고
    • Matrix metalloproteinases as master regulators
    • Lynch CC,. 2010. Matrix metalloproteinases as master regulators. Bone 48: 44-53.
    • (2010) Bone , vol.48 , pp. 44-53
    • Lynch, C.C.1
  • 18
    • 84855392626 scopus 로고    scopus 로고
    • An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment
    • Thiolloy S, Edwards JR, Fingleton B, et al., 2012. An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment. PLoS ONE 7: e29862.
    • (2012) PLoS ONE , vol.7 , pp. e29862
    • Thiolloy, S.1    Edwards, J.R.2    Fingleton, B.3
  • 19
    • 33750738067 scopus 로고    scopus 로고
    • Basic mechanisms responsible for osteolytic and osteoblastic bone metastases
    • Guise TA, Mohammad KS, Clines G, et al., 2006. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clin Cancer Res 12: 6213s-6216s.
    • (2006) Clin Cancer Res , vol.12 , pp. 6213s-6216s
    • Guise, T.A.1    Mohammad, K.S.2    Clines, G.3
  • 20
    • 84862561863 scopus 로고    scopus 로고
    • Modern interpretation of giant cell tumor of bone: Predominantly osteoclastogenic stromal tumor
    • Yuhree K, Saqib N, Hana G, et al., 2012. Modern interpretation of giant cell tumor of bone: predominantly osteoclastogenic stromal tumor. Clin Orthop Surg 4: 107-116.
    • (2012) Clin Orthop Surg , vol.4 , pp. 107-116
    • Yuhree, K.1    Saqib, N.2    Hana, G.3
  • 21
    • 18544399193 scopus 로고    scopus 로고
    • Identification of markers of possible prognostic value in 57 giant cell tumors of bone
    • Gamberi G, Serra M, Ragazzini P, et al., 2003. Identification of markers of possible prognostic value in 57 giant cell tumors of bone. Oncol Rep 10: 351-356.
    • (2003) Oncol Rep , vol.10 , pp. 351-356
    • Gamberi, G.1    Serra, M.2    Ragazzini, P.3
  • 22
    • 0035023776 scopus 로고    scopus 로고
    • Detection of c-fos expression in benign and malignant musculoskeletal lesions
    • Weisstein JS, Majeska RJ, Klein MJ, et al., 2001. Detection of c-fos expression in benign and malignant musculoskeletal lesions. J Orthop Res 19: 339-345.
    • (2001) J Orthop Res , vol.19 , pp. 339-345
    • Weisstein, J.S.1    Majeska, R.J.2    Klein, M.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.